Fragment-type 4-azolylcoumarin derivatives with anticancer properties.
Simic M, Petkovic M, Jovanovic P, Jovanovic M, Tasic G, Besu I, Zizak Z, Aleksic I, Nikodinovic-Runic J, Savic V.
Simic M, et al.
Arch Pharm (Weinheim). 2021 Nov;354(11):e2100238. doi: 10.1002/ardp.202100238. Epub 2021 Aug 10.
Arch Pharm (Weinheim). 2021.
PMID: 34374111